Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference
Intellia will webcast its September 14, 2026 Morgan Stanley healthcare conference presentation with a replay available for about three months.
Rhea-AI Summary
Intellia Therapeutics (NTLA) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 4:05 p.m. ET.
A live webcast will be accessible via the Events and Presentations page in the Investors & Media section of Intellia’s website, with a replay available for approximately 90 days.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 07 | Inducement grants | Neutral | +0.7% | Eight employees received inducement restricted stock units totaling 38,200 shares. |
| Aug 06 | Quarterly earnings | Positive | +2.5% | Q2 results included positive Phase 3 HAELO data and 2028 cash runway. |
| Jul 30 | Conference scheduling | Neutral | +2.7% | Scheduled conference call and webcast to discuss second-quarter results and business updates. |
| Jul 06 | Inducement grants | Neutral | -2.3% | Thirteen employees received inducement restricted stock units totaling 53,250 shares. |
| Jun 05 | Inducement grants | Neutral | -0.4% | Six employees received inducement restricted stock units totaling 47,150 shares. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
NTLA showed a positive response to its recent earnings release but mixed reactions to conference scheduling and inducement-grant announcements.
Key Terms
crispr technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that the company will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 4:05 p.m. ET.
A live webcast will be available on the Events and Presentations page in the Investors & Media section of Intellia’s website, www.intelliatx.com. A replay of the webcast will be available on Intellia’s website for approximately 90 days.
About Intellia Therapeutics
Intellia Therapeutics, Inc. (Nasdaq: NTLA) is a leading clinical-stage biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. The company’s mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments. With deep scientific, technical and clinical development experience, Intellia aims to reset the standard for medicine by durably treating the root causes of disease. Learn more at intelliatx.com and follow us @intelliatx.
Investor Contact:
Jason Fredette
Vice President, Investor Relations and Corporate Communications
Intellia Therapeutics, Inc.
jason.fredette@intelliatx.com
Media Contact:
Mike Tattory
Vice President
LifeSci Communications
mtattory@lifescicomms.com
FAQ
When will Intellia Therapeutics (NTLA) present at the Morgan Stanley 24th Annual Global Healthcare Conference?
Intellia Therapeutics (NTLA) is scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 4:05 p.m. ET.
How can investors access the live webcast of Intellia Therapeutics (NTLA) at the Morgan Stanley conference?
A live webcast of Intellia Therapeutics’ presentation will be available on the Events and Presentations page in the Investors & Media section of the company’s website at www.intelliatx.com.
Will a replay be available for Intellia Therapeutics (NTLA) Morgan Stanley conference webcast?
Yes. A replay of Intellia Therapeutics’ webcast from the Morgan Stanley 24th Annual Global Healthcare Conference will be available on the company’s website for approximately 90 days.